Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04328532

MRI Screening of Placenta Adhesion Abnormalities

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
71 (estimated)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Placenta Adhesion Abnormalities (PAA) are the consequence of an excessive invasion of the placenta within the myometrium. PAA are related to severe maternal pregnancy outcomes, especially in case of incidental discovery during delivery that increase the risk of intraoperative massive bleeding, hysterectomy and even maternal death. Ultrasound is the standard modality for diagnosing PAA, but Magnetic Resonance Imaging (MRI) has been increasingly performed in the case of inconclusive sonographic findings. However, standard morphological MRI sequences appear as insufficient to improve the sensitivity and specificity values for detecting PAA, while quantitative MRI may be more efficient. The main objective of this study is to characterize the diagnostic performance of quantitative MRI parameters (mainly Apparent Diffusion Coefficient, T2 and T2\*) reflecting placental perfusion and/or oxygenation at high field, without injection of gadolinium-based agent, for the detection of PAA in women with ongoing pregnancy between 30 and 38 weeks of gestation with risk factors for PPA.

Conditions

Interventions

TypeNameDescription
DEVICEMRIMRI examination (45 min max) with potential oxygen delivery for 10 min

Timeline

Start date
2020-10-21
Primary completion
2026-10-21
Completion
2026-10-21
First posted
2020-03-31
Last updated
2025-02-13

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04328532. Inclusion in this directory is not an endorsement.